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Abstract
Background: Pre-operative antibody levels have been shown to be inversely related to development of
post-operative complications. Staphylococcal infection is a major source of morbidity following surgery.
Methods: We examined the variability of anti-staphylococcal antibody levels across a group of healthy volunteers
and compared this with patients scheduled to undergo cardiac surgery.
Results: Pre-operative cardiac surgical patients exhibited significantly higher levels of staphylococcal antibodies
compared with healthy volunteers.
Conclusions: The relationship between pre-surgery staphylococcal antibody levels and outcome warrants further
investigation.
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Background
The incidence of wound infection following cardiac sur-
gery is approximately 1–4 %, of which approximately
one fifth is due to methicillin-resistant Staphylococcus
aureus (MRSA) (Allen et al. 2014). Post-operative MRSA
infection is associated with a mortality ranging from 10
to 14 % (Ridderstolpe et al. 2001). In addition, there is a
considerable cost both economically and in terms of pa-
tient suffering that result from sternal wound breakdown,
staphylococcal septicaemia and the associated increased
length of hospital stay (Coskun et al. 2005). Kanafani dem-
onstrated that whilst certain pre-operative characteristics
were associated with an increased risk of post-operative
staphylococcal sepsis, the majority of those that developed
such complications had no such risk factors (Kanafani et
al. 2009). These patients had no measure made of their
underlying immunity to Staphylococcus. Similarly, in one
of the largest retrospective studies of cardiac surgical
patients (n > 330,000), there were again relationships
drawn between pre-operative risk factors such as body
mass index (BMI), diabetes, chronic renal insufficiency, in-
creasing age and immunosuppressive therapy and devel-
opment of infective complications (Fowler et al. 2005). In
this study, again, no measure had been made of the pa-
tients’ own underlying ability to resist infection.
The humoral immune system provides a level of pro-
tection to patients against a number of infective/inflam-
matory conditions and indeed our own institution has
been involved in demonstrating links between low levels
of pre-operative antibody against endotoxin and outcome
following cardiac surgery (Hamilton-Davies et al. 1997;
Bennett-Guerrero et al. 1997). It is likely that everyone has
a varying level of antibodies to common infective organ-
isms, thus maintaining a degree of circulating immunity to
these organisms, and that these antibodies are functional,
i.e. have neutralising or opsonizing functions.
It has been shown that the alpha-toxin fragments se-
creted by Staphylococcus can impair gut mucosal integrity
and thus further worsen the potential for sepsis by enabling
Gram-negative organism/endotoxin translocation from the
gut lumen (Kwak et al. 2012).
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Anti-staphylococcal antibodies to a variety of epitopes
can be measured by enzyme-linked immunosorbent
assay (ELISA) (PhPlate AB, Stockholm, Sweden) (Colque-
Navarro et al. 1998), and the levels of these antibodies are
likely to vary between individuals. It is well established
that there is considerable variation in antibody levels in
healthy volunteers and in infected patients (Dryla et al.
2005). This is similar to the variation in levels of endogen-
ous endotoxin antibodies, which are predictive of post-
operative complications (Down et al. 2004).
We are particularly interested in those patients who
develop serious S. aureus infections (deep-seated wound
infection, serious bacteraemia, endocarditis) and exam-
ining whether there is a relationship with the patient’s
own immune state. We set out to determine if these
antibodies were measurable in individuals (healthy vol-
unteers and pre-operative cardiac surgical patients) and
whether there was measurable variation in antibody levels
in these two groups. We planned to study the younger
volunteers as they were likely to have an active, healthy
immune system as compared to the patient group who
may be expected to exhibit a degree of immunosenescence
and have lower levels of circulating antibodies.
We chose to assay for antibodies to alpha-toxin (AT),
an extracellular polypeptide, and to teichoic acid (TA), a
major surface antigen of the staphylococcal organism;
both are present in almost all strains of S. aureus. A high
proportion (86–95 %) of the S. aureus isolates in clinical
infections produce an anti-alpha-toxin antibody response
(Mollby 1983) (Fig. 1). In cases of serious staphylococcal in-
fection, the levels of alpha-toxin have been demonstrated to
be very high, suggesting that the antigen is highly immuno-
genic (Soderquist BC-N et al. 1993). Teichoic acid is par-
ticularly expressed in case of long-standing staphylococcal
infection, for example, deep-seated wound infection or
endocarditis (Colque-Navarro et al. 1998). These two
antibody types are likely to be reliably expressed in
those patients that we are most interested in studying;
those that develop deep-seated staphylococcal wound
infections following cardiac surgery.
The IgG class of antibody is likely to be a more reliable
indicator due to the reliability in appearance and longevity
of response. Peak levels of the IgM class may be missed
due to its more transient nature (Barclay 1995).
This investigation formed the first part of an ongoing
investigation into peri-operative staphylococcal antibody
levels and clinical outcome. As this was a pilot study
and we were uncertain as to the degree of variation in
antibody levels within and between the groups, we did
not perform power calculations. The results of this in-
vestigation will help with the prediction of sample sizes
in our future studies.
Fig. 1 Categorised antibody response (positive, weakly positive, negative) to alpha-toxin and teichoic acid domains in healthy volunteers (HV),
n = 25, and in pre-operative cardiac surgical patients (PS), n = 25. Fisher’s exact test (Freeman-Halton extension) used to test variability of response
between groups
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Hypotheses
There is a measurable intra-population and inter-population
variability in anti-staphylococcal antibodies amongst
different populations of individuals.
Methods
Ethical approval for this study was given by the Joint
UCL/UCLH Committee on the Ethics of Human Research
(Committee Alpha), REC reference 05/Q0502/72.
Prior to enrolment, verbal and written information was
provided to all participants after which verbal and written
consent to participate was obtained. No individual identifi-
able data is included in this submission.
Twenty-five healthy volunteers (HV) and 25 pre-
operative cardiac surgery patients (PS) were recruited
into the study, provided with study information and
asked for written, informed consent for collection of
7 mL blood into a plain tube (Becton-Dickinson, Oxford,
UK) for later analysis. Exclusion criteria were age under
18 years, recent or ongoing infection, pregnancy, an
immunosuppressive condition and concomitant use of
immunosuppressive therapy.
The patient group was consecutively recruited from a
population scheduled to undergo a variety of cardiac sur-
gical procedures. There were no refusals to participate in
the study.
Sample analysis
The 7-mL blood samples were allowed to clot at room
temperature for 20 min, centrifuged for 10 min at
3000 rpm and the serum removed by pipette into cryo-
tubes for storage at −70 °C for later analysis (Thermo
Scientific, MA, USA). The ELISA procedure has been
detailed previously. Briefly, coating doses for the 96-well
microtitration plates (Dynatech M-129B, Plochingen,
Germany) with α-toxin and teichoic acid were established
at 2.5 and 1 μg/mL, respectively. The working volume
throughout the tests was 100 μL/well. The microtitration
plates were coated with antigens diluted in phosphate-
buffered saline (PBS), pH 7.4, and incubated overnight at
22 °C. The plates were washed and a serum dilution in
PBS with Tween-20 0.05 % v/v (PBS-T) of 1 in 1000 for
α-toxin and a 1 in 10,000 for teichoic acid was added to
the two coated wells. Positive and negative controls
were included in each plate. The plates were incubated
for 1 h at room temperature (20 °C). After washing the
plates, alkaline phosphatase-conjugated goat anti-human
antibody (Sigma) diluted in PBS-T was added to each well,
and the plates were incubated for 2 h at room temperature.
After the final wash, p-nitrophenyl-phosphate substrate
(Sigma) was added. Titres were read when the positive
controls reached previously established values at 405 nm
on a Titertek Multiskan (Flow Laboratories, Irvine,
Scotland) instrument. Antibody levels were categorised
to a low, intermediate and high response to the teichoic
acid and alpha-toxin domains. Statistical analysis compar-
ing the variability in proportions of response between the
groups was performed using the Freeman-Halton exten-
sion of Fisher’s exact test. Probabilities are two tailed.
Results
A total of 25 healthy volunteers were recruited with a
mean age of 41 years (range 27–51) and included 17 males
and 8 females. Twenty-five pre-operative patients were
also recruited with a mean age of 62 years (range 19–78)
and included 17 males and 8 females. The surgical proce-
dures undertaken on these patients were coronary artery
bypass grafts (CABG)—9, valve replacement—10, CABG+
valve—5 and atrial septal defect repair—1.
Antibody levels to both AT and TA were obtained for
all participants.
The patterns of distribution of each classification (low,
intermediate or high) for AT and TA antibody levels ap-
peared to differ between the two study groups (Fig. 1). A
striking element of the results was the proportion of pa-
tients in the pre-surgery group with high antibody levels
to alpha-toxin (48 % vs. 0) and to teichoic acid (32 vs.
8 %) when compared with the healthy volunteer group.
The distribution of classification for alpha-toxin in the
HV group (low = 25, intermediate = 0, high = 0) differed
significantly from that in the PS group (11, 2, 12, re-
spectively); p < 0.0001. The distribution of each classifi-
cation for TA antibody level in the HV group (16, 7, 2)
did not vary significantly from that of the PS group (13,
4, 8); p = 0.09.
Amongst the HV group, the distribution of classifica-
tion of response to AT (25, 0, 0) differed from that to
TA (16, 7, 2); p = 0.002. However, in the PS group, the
distribution of response to the two tests did not differ,
AT (11, 2, 12) vs. TA (13, 4, 8); p = 0.41.
Discussion
It is expected that antibody levels to an antigen will vary
between individuals and that the response to various an-
tigens will also vary in any given individual (Dryla et al.
2005). Both the healthy volunteers and the pre-operative
patients were assumed to be in reasonable health with
respect to any ongoing infection, and none were thought
to have a concurrent infection at the time of study. The
cohort of healthy volunteers had a significantly lower
mean age than the pre-surgery group and would thus be
reasonably expected to have higher antibody levels as, in
general, downgraded immune responsiveness or immu-
nosenescence is seen with advancing age (Haq and
McElhaney 2014). This was not seen, and indeed, the
pre-cardiac surgical group had a greater proportion of
high antibody levels to both teichoic acid and alpha-
toxin. Subjects with a recent infection may well have
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higher antibody levels than those in a non-infected
group (Dryla et al. 2005). It may be that the pre-surgery
group had been exposed to a significant staphylococcal
challenge whereas the healthy cohort had not. Consider-
ing the different populations and looking at any obvious
invasive procedure that the surgical group had under-
gone when compared to the healthy volunteers, we felt
that cardiac catheterisation was the universally most in-
vasive. It may be that the aseptic technique during the
cardiac catheterization process, or during some other
temporally related procedure such as peripheral venous
cannulation, was inadequate. This hypothesis would
need to be tested by comparing antibody levels before
and after cardiac catheterisation procedures. There could,
of course, be other factors that may lead to a differing level
of antibodies between the groups. Pre-operative blood
testing and venous cannulation will likely have occurred in
the patient group.
It would also be interesting and useful to measure
antibody levels in healthy volunteers of the same age range
as pre-operative patients or perhaps measuring antibody
levels in older patients not scheduled to undergo cardiac
surgery. Any observed differences between these two
groups may imply that another mechanism might be the
cause of antibody level variation.
The variation in antibody levels in the pre-operative
patient group, all of whom had a similar potential inocu-
lative insult, may be due to a natural variation in anti-
body levels between individuals but also may represent
variability in the individual’s ability to generate an im-
mune response. Some patients generated a high level of
antibody and others generated low or no response. Do
those patients with low antibody levels suffer a different
level of peri-operative complication than those with
higher levels?
The association between low pre-operative antibody
levels and compromised outcome following cardiac surgery
has already been made for endotoxin core antibodies
(EndoCAb) (Hamilton-Davies et al. 1997; Bennett-Guerrero
et al. 1997). In this pilot study, no outcome comparisons
could be made due to small numbers and heterogeneity of
both the patients and the surgical procedures. The variabil-
ity in underlying immunity to both teichoic acid and alpha-
toxin observed in pre-cardiac surgery patients suggests that
a controlled outcome study be performed in this group.
The ability of pre-operative staphylococcal antibody levels
to predict post-operative infectious outcomes could be en-
hanced by perhaps combining with other antibody levels
(e.g. EndoCAb).
If an inverse relationship between pre-operative anti-
staphylococcal antibody levels and subsequent develop-
ment of post-cardiac surgery complications exists, similar
to that for EndoCAb, it may be possible to intervene to
modify the post-procedural outcome.
It has been previously reported by Colque-Navarro
and colleagues that those patients with low levels of anti-
bodies, especially to alpha-toxin, may not mount much of
a response to antigenic exposure (Colque-Navarro et al.
1998). This may reflect a more generalised immune hypo-
responsiveness where active vaccination might not gener-
ate an adequate response. Passive immune therapy, such
as the administration of a gammaglobulin product, may be
more appropriate. It may be that for patients with a defi-
cient pre-operative immune status, an alternative, less in-
vasive, surgical or non-surgical intervention may be
available and appropriate.
Conclusions
This demonstration of the variability in anti-staphylococcal
antibody levels suggests that the relationship between
pre-surgery staphylococcal antibody levels and outcome
warrants further investigation. Predicting which patients
are more likely to suffer a complicated course following
surgery might enable either more effective redirection of
those patients to other appropriate treatment modalities
or targeting specific resources to those patients to give
them the best chance of dealing with the surgical insult.
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